Tele-Collaborative Outreach to Rural Patients With Chronic Pain
NCT ID: NCT06091202
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
608 participants
INTERVENTIONAL
2024-07-11
2027-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reaching Rural Veterans: Applying Mind-Body Skills for Pain Using a Whole Health Telehealth Intervention - UG3 Pilot Study
NCT06568250
Telehealth Therapy for Chronic Pain: Comparison of In-person vs. Video-administered ACT for Pain
NCT01055639
IMproving Pain Using Peer RE-inforced Self-management Skills
NCT01748227
Tailored Non-Pharmacotherapy Services for Chronic Pain
NCT04523714
Cooperative Pain Education and Self-management
NCT02724930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Veterans who enroll will participate for 12-months and will be randomized to one of 2 groups: 1) CORPs (with access to a nurse by phone/video for the duration of the study), or 2) One-time education session with the nurse by phone/video to review resources for pain. All participants complete research assessments at the start of the study, and at 3-, 6-, 9-, and 12-months by phone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CORPs Intervention
The CORPs Intervention is a nurse-led intervention.
A) An intake assessment with a Nurse Care Manager at the start of the study by phone or video to discuss the patient's pain experience, care options, and goals. Resources are provided and focus on non-medication options at the VA, and as appropriate, in the community.
B) 5 Check-in phone/video appointments with a Nurse Care Manager, scheduled to take place near 2-, 4-, 8-, 12-, and 16-weeks. These visits will provide further assistance with goal planning and care coordination for pain management.
C) Optional 6-week virtual group education class covering topics like complementary and integrative approaches to pain, sleep and pain, and the neurobiology of pain.
D) Patients in this arm can contact their nurse with questions for the full 12 months of participation.
CORPs Intervention
Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference.
After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months.
A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.
Minimally Enhanced Usual Care (MEUC)
The minimally enhanced usual care arm is a one-time education session.
A) One-time education session with a Nurse Care Manager by phone/video to review pain resources. These resources focus on non-medication options at the VA, and as appropriate, in the community.
Minimally Enhanced Usual Care (MEUC)
Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference.
After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months.
A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CORPs Intervention
Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference.
After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months.
A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.
Minimally Enhanced Usual Care (MEUC)
Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference.
After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months.
A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Rural Residence based on Rural Urban Commuting Area codes
* High Impact Chronic pain, determined through a phone screening
* Access to landline or cell phone
* English Speaking
Exclusion Criteria
* Plans to move in the next 3 months
* Surgery in the past 3 months
* In long-term inpatient or hospice care
* Terminal illness (defined as life expectancy of less than 12 months)
* Active participation in another pain intervention study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
Portland VA Medical Center
FED
Minneapolis Veterans Affairs Medical Center
FED
North Texas Veterans Healthcare System
FED
VA Tennessee Valley Health Care System
FED
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Travis Lovejoy
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Travis Lovejoy, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Oregon Health & Science University, VA Portland Health Care System
Benjamin Morasco, PhD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health & Science University, VA Portland Health Care System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Minneapolis Health Care System
Minneapolis, Minnesota, United States
VA Portland Health Care System
Portland, Oregon, United States
VA Tennessee Valley Health Care System
Nashville, Tennessee, United States
VA North Texas Health Care System
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.